Ripple Neuro Listed by insomnia Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

Ransomware groups continue to target specialized technology and medical-device firms, where proprietary research and operational data can carry high leverage in double-extortion schemes. In this landscape, listings on criminal leak sites have become a routine pressure tactic, even when independent confirmation remains limited.

On February 14, 2025, the ransomware group known as insomnia listed Ripple Neuro as a victim, claiming to have exfiltrated internal files in a ransomware attack. The number of people affected is unknown, and public detail on the precise scope remains limited. The incident matters because Ripple Neuro develops tools used in neuroscience research and electrophysiology, sectors that routinely handle sensitive technical and potentially regulated information.

What happened

According to the available record, Ripple Neuro was listed by the insomnia ransomware group on February 14, 2025. The group claims that internal files were exfiltrated as part of a ransomware attack. No confirmed figure for individuals affected has been published, and further operational details—such as the initial access method, the exact volume of data, or any ransom demand—are undisclosed in public reporting. The listing itself constitutes the primary public claim; independent verification of the intrusion or the contents of any stolen archive has not been provided in the facts available.

Inside insomnia

Insomnia is a ransomware operation that follows the now-common double-extortion model: encrypting systems while also claiming to steal data and threatening to publish it if payment is not made. Like many such groups, it maintains a leak site where it posts victim names and, at times, sample files to increase pressure. Public reporting on the group describes typical tactics that include exploitation of exposed services, credential abuse, and lateral movement once inside a network, followed by data staging and encryption. Prior activity attributed to insomnia has involved a range of commercial and specialized targets, though each listing must be treated as an unverified claim until corroborated. In the present case, the group asserts that it obtained internal files from Ripple Neuro; no additional statements from the group about this specific victim appear in the available facts.

Who is Ripple Neuro?

Ripple Neuro designs and supplies neuroscience research tools and medical devices focused on electrophysiology. Its product range includes portable wireless processors, implantable technology, and accessories compatible with various experimental models. The company serves researchers working in brain-computer interfaces, closed-loop stimulation, and wireless signal acquisition. Organizations of this type typically maintain design files, firmware, experimental protocols, customer and collaborator records, and internal operational documents. A breach involving such an entity is consequential because the data can include proprietary intellectual property, research configurations, and information that may fall under medical-device or research-compliance frameworks, even when the precise contents of any stolen material remain unconfirmed.

What was likely exposed

The facts state that internal files were exfiltrated in a ransomware attack. No further breakdown of data types—such as personal identifiers, patient-related records, source code, or financial documents—has been disclosed. Organizations operating in electrophysiology and brain-computer-interface research commonly hold technical drawings, device firmware, experimental datasets, employee and collaborator contact information, and contractual materials. Because the exact inventory of the claimed archive has not been published or independently verified, it is not possible to state with certainty which of these categories, if any, were involved. The exposure therefore remains described only at the level of “internal files.”

Why it matters

For individuals whose information may have been among the internal files, the practical risks include potential misuse of contact details, credentials, or any research-related personal data that could enable phishing or identity-related fraud. For the organization, the consequences can include disruption of research collaborations, exposure of proprietary designs that competitors or other actors might exploit, and the operational cost of incident response and system restoration. In the medical-device and neuroscience-tool sector, even limited leakage of technical material can raise questions about supply-chain integrity and regulatory expectations. Because the number of affected people is unknown and the precise data types are unconfirmed, the full extent of harm cannot yet be quantified; the listing alone, however, places both the company and any associated parties on notice that sensitive material may be circulating in criminal channels.

What to do if you're exposed

If you have a relationship with Ripple Neuro—as an employee, collaborator, customer, or research partner—monitor accounts for unusual activity and treat unsolicited messages that reference the company with caution. Change passwords on any related systems, enable multi-factor authentication where available, and review financial and email accounts for signs of misuse. Because the scale of personal data involved is unknown, consider placing fraud alerts with credit bureaus if you believe your identifiers could have been present. Readers can also run a free exposure scan of their email address to check whether that address has already appeared in known breach datasets, providing an early indication of wider exposure.

AICompiled with AI assistance from public sources and published under our editorial standards.